Abstract:Circulating tumor cells (CTCs) have been well-established as promising biomarkers that can be leveraged to gauge the prognosis of patients with cancers and to guide patient treatment efforts. Although the scarcity of CTCs within peripheral circulation and the associated phenotypic changes that they exhibit owing to the epithelial-mesenchymal transition (EMT) process make the reliable isolation of these cells very challenging. Recently, several studies have discussed platforms capable of mediating the efficient and sensitive isolation of CTCs, but these approaches are nonetheless subject to certain limitations that preclude their clinical application. For example, these platforms are poorly-suited to minimizing damage in the context of cellular capture and release or the in vitro culture of captured cells for subsequent molecular analyses, which would better enable clinicians to select appropriate precision treatments on an individualized basis. In this study, we report the layer-by-layer assembly approach to synthesize a novel composite nanomaterial consisting of modified zirconium-based metal-organic-frameworks (MOFs) on the surface of magnetic beads with dual antibody surface modifications capable of capturing CTCs without being hampered by the state of cellular EMT process. Our analyses indicated that these dual antibody-modified nanomaterials exhibited greater capture efficiency than that observed for single antibody. Importantly, captured cells can be gradually released following capture and undergo subsequent in vitro proliferation following water molecule-induced MOF structural collapse. This release mechanism, which does not require operator intervention, may be effective as a means of minimizing damage and preserving cellular viability such that cells can be more reliably utilized for downstream molecular analyses and associated treatment planning. To further confirm the potential clinical applicability of the developed nanomaterial, it was successfully utilized for capturing CTCs from peripheral blood samples collected from cases diagnosed with gastrointestinal tumors.

Efficient Isolation of Circulating Tumor Cells Using Ultra-Convenient Substrates Based on Self-Assembled Hollow MnO2 Nanoparticles

Efficient Capture and High Activity Release of Circulating Tumor Cells by Using TiO2 Nanorod Arrays Coated with Soluble MnO2 Nanoparticles

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Effective Capture and Release of Circulating Tumor Cells Using Core-Shell Fe 3 O 4 @mno 2 Nanoparticles

High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (ctcs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles

Effective Isolation, Label and Release of Multitype Circulating Tumor Cells Base on CdSe/ZnS Quantum Dots and Dual-antibody Modified Magnetic Nanoparticles

Biospecific Monolayer Coating for Multivalent Capture of Circulating Tumor Cells with High Sensitivity

TiO2 Nanopillar Arrays Coated with Gelatin Film for Efficient Capture and Undamaged Release of Circulating Tumor Cells

Highly Efficient Circulating Tumor Cell Isolation from Whole Blood and Label-Free Enumeration Using Polymer-Based Microfluidics with an Integrated Conductivity Sensor

Capture and Release of Cancer Cells Based on Sacrificeable Transparent MnO2 Nanospheres Thin Film.

Quick-response Magnetic Nanospheres for Rapid, Efficient Capture and Sensitive Detection of Circulating Tumor Cells.

Generally Applicable Circulating Tumor Cell Enrichment and Identification Through a Membrane Glycoprotein-Targeting Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling.

Cell-Released Magnetic Vesicles Capturing Metabolic Labeled Rare Circulating Tumor Cells Based on Bioorthogonal Chemistry

Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells

Cell‐Friendly Isolation and pH‐Sensitive Controllable Release of Circulating Tumor Cells by Fe 3 O 4 @CaCO 3 Nanoplatform

Engineered Red Blood Cells For Capturing Circulating Tumor Cells With High Performance

Rapid prototyping of Nanoroughened polydimethylsiloxane surfaces for the enhancement of immunomagnetic isolation and recovery of rare tumor cells

Combining hybrid cell membrane modified magnetic nanoparticles and inverted microfluidic chip for in situ CTCs capture and inactivation

Rapid and efficient isolation and detection of circulating tumor cells based on ZnS:Mn 2+ quantum dots and magnetic nanocomposites.

Facile, rapid and efficient isolation of circulating tumor cells using aptamer-targeted magnetic nanoparticles integrated with a microfluidic device

Circulating Tumor Cell Isolation: Efficient Purification and Release of Circulating Tumor Cells by Synergistic Effect of Biomarker and SiO2@Gel‐Microbead‐Based Size Difference Amplification (adv. Healthcare Mater. 13/2016)